Costa Rica's Medtech Shift: From Assembly to Engineering

Jan de Vries · 2026-11-06

Costa Rica isn't just assembling medical devices anymore. It's moving up the value chain, and that shift could change how medtech companies think about nearshoring. For years, the country built its reputation on manufacturing—catheters, surgical instruments, and other devices rolling off production lines. But now, the focus is expanding into engineering, supplier networks, and digital capabilities. The goal? Attract higher-value investment and keep more of the supply chain onshore. ### Why the Shift Matters Manufacturing alone can only take you so far. Labor costs rise, competition intensifies, and companies start looking for the next low-cost hub. By building out engineering and digital skills, Costa Rica is hedging against that race to the bottom. "We're not just making devices; we're designing them," says a local industry insider. That's a big deal for medtech firms looking to shorten lead times and collaborate more closely with their production partners. ### The Building Blocks So what's actually changing on the ground? A few things stand out: - **Engineering talent:** Universities and technical schools are churning out more biomedical engineers, and companies are setting up R&D centers to tap into that pool. - **Supplier ecosystem:** Instead of importing every component, local suppliers are stepping up to provide specialized parts and services, reducing dependency on long overseas shipments. - **Digital infrastructure:** From IoT-enabled factories to data analytics, Costa Rica is investing in the digital backbone that modern medtech requires. ### What It Means for US Companies For US medtech firms, this evolution offers a compelling alternative to far-flung manufacturing hubs. Costa Rica is just a few hours by plane from major US cities, and the time zone alignment makes collaboration easier. Plus, the country has a stable political environment and a strong track record in medical devices—it's already the largest exporter of medical devices in Latin America. But it's not just about convenience. As the country builds engineering depth, US companies can offload more complex tasks—like design validation or process automation—without sending them to the other side of the world. That could speed up innovation cycles and reduce risk. ### The Road Ahead Of course, challenges remain. Scaling engineering talent takes time, and the digital transformation is still a work in progress. But the direction is clear. Costa Rica is betting that by moving up the value chain, it can attract a new wave of investment—and become a true medtech partner, not just a manufacturing destination. For an industry always looking for an edge, that's a bet worth watching.